drugset / Trial / NCT01755572

Blood Pressure Outcomes With Liraglutide Therapy

NCT01755572

RandomizedCrossoverTriple-blindBasic science

Summary

Purpose: The purpose of this study is to further study the mechanism by which liraglutide, a relatively new anti-hyperglycemic medication, might lower blood pressure in patients with Type 2 diabetes and high blood pressure.

Timeline

Start
2013-01
Primary completion
2014-01
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide 1.8 mg